Biotech Co., Ltd. announced that the company completed the share repurchase on September 5, 2026. The repurchase implementation period is from June 5, 2026 to September 5, 2026. The purpose of the repurchase is to protect the company's value and shareholders' rights. The company has repurchased a total of 239.225 million shares through centralized bidding transactions, accounting for 2.17% of the company's total share capital. The repurchase price range is 11.12 yuan/share - 14.04 yuan/share, the average repurchase price is 12.54 yuan/share, and the total capital used is 299.662 million yuan, which is in line with the originally disclosed repurchase amount range of 20 million yuan to 40 million yuan and the maximum repurchase price requirement of 20.70 yuan/share. All repurchased shares are held in the company's special securities account for repurchase. If no sale is carried out within 3 years, they will be cancelled after partial fulfillment procedures have not been implemented.

Zhitongcaijing · 1d ago
Biotech Co., Ltd. announced that the company completed the share repurchase on September 5, 2026. The repurchase implementation period is from June 5, 2026 to September 5, 2026. The purpose of the repurchase is to protect the company's value and shareholders' rights. The company has repurchased a total of 239.225 million shares through centralized bidding transactions, accounting for 2.17% of the company's total share capital. The repurchase price range is 11.12 yuan/share - 14.04 yuan/share, the average repurchase price is 12.54 yuan/share, and the total capital used is 299.662 million yuan, which is in line with the originally disclosed repurchase amount range of 20 million yuan to 40 million yuan and the maximum repurchase price requirement of 20.70 yuan/share. All repurchased shares are held in the company's special securities account for repurchase. If no sale is carried out within 3 years, they will be cancelled after partial fulfillment procedures have not been implemented.